celecoxib has been researched along with Arthritis, Spinal in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyze the changes in the levels of bone metabolism markers related to sacroiliac joint (SIJ) inflammation in patients with axial spondyloarthritis (axSpA) after treatment with imrecoxib and celecoxib and evaluate their relationship with clinical efficacy." | 8.31 | Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis. ( Chen, Y; Gao, G; Guo, Y; Jiang, D; Li, T; Mai, Z, 2023) |
| "To analyze the changes in the levels of bone metabolism markers related to sacroiliac joint (SIJ) inflammation in patients with axial spondyloarthritis (axSpA) after treatment with imrecoxib and celecoxib and evaluate their relationship with clinical efficacy." | 4.31 | Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis. ( Chen, Y; Gao, G; Guo, Y; Jiang, D; Li, T; Mai, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Min, HK | 1 |
| Choi, J | 1 |
| Lee, SY | 1 |
| Lee, AR | 1 |
| Min, BM | 1 |
| Cho, ML | 1 |
| Park, SH | 1 |
| Guo, Y | 1 |
| Jiang, D | 1 |
| Mai, Z | 1 |
| Chen, Y | 1 |
| Li, T | 1 |
| Gao, G | 1 |
| Gao, GM | 1 |
| Li, YM | 1 |
| Zheng, XL | 1 |
| Jiang, DB | 1 |
| Zhang, LL | 1 |
| Xu, PH | 1 |
| Liu, SY | 1 |
| Zheng, ZH | 1 |
| Kan, QC | 1 |
1 trial available for celecoxib and Arthritis, Spinal
| Article | Year |
|---|---|
The Efficacy of Imrecoxib and Celecoxib in Axial Spondyloarthritis and Their Influence on Serum Dickopff-Related Protein 1 (DKK-1) Levels.
Topics: Biomarkers; Celecoxib; Demography; Follow-Up Studies; Humans; Inflammation; Intercellular Signaling | 2017 |
2 other studies available for celecoxib and Arthritis, Spinal
| Article | Year |
|---|---|
Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis.
Topics: Animals; beta-Glucans; Celecoxib; Cytokines; Disease Models, Animal; Disease Progression; Female; Ge | 2022 |
Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis.
Topics: Axial Spondyloarthritis; beta Catenin; Celecoxib; Core Binding Factor Alpha 1 Subunit; Humans; Infla | 2023 |